Nasdaq
Bionano Genomics Announces 1-for-10 Reverse Stock Split
The San Diego-based optical genome mapping company said the reverse stock split will take effect on Friday afternoon after the market closes.
Genetic Technologies Gets Nasdaq Delisting Warning
The Australian genomic testing company said that its American Depositary Shares have failed to meet the Nasdaq's minimum bid price requirement for continued listing.
Centogene Regains Compliance With Nasdaq Listing Requirements
The company had already regained compliance with Nasdaq's requirements once before this year, after missing the minimum bid price requirement last December.
Centogene Receives Noncompliance Notice From Nasdaq Over Market Value of Shares
The market value of the company's publicly held shares has fallen below $15 million for 30 consecutive business days, triggering the notification.
Genetron Health Receives Nasdaq Noncompliance Notice
The Chinese cancer molecular profiling company has 180 calendar days, or until Nov. 13, to regain compliance with the Nasdaq minimum bid price requirement.